News / Nov 11, 2019
Hovione is winner of the 16th CPhI Pharma Awards
PRIME wins the CPhI Pharma Award
Press Room
News / Nov 11, 2019
Portugal’s Annual "St. Martin's Day" & 60th Anniversary Dinner
Hovione Macau organized the St. Martin's Day in our manufacturing facility in Macau
Article / Nov 01, 2019
Hovione Technology: Dry powder inhalers towards effective affordable sustainable respiratory healthcare
On Drug Delivery, November 2019
News / Oct 30, 2019
Hovione’s innovative solutions nominated for CPhI awards 2019
Learn more about the innovations from our scientists
News / Oct 08, 2019
Celebrating our 60th Anniversary in Cork
10 years in Cork, 60 years in the world.
News / Sep 23, 2019
Hovione is a Best For The World 2019 Honoree
The Best For The World lists are determined based on the verified B Impact Assessments of Certified B Corporations
Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
Press Clipping / Sep 13, 2019
Kiel University and Hovione to develop high-dose inhalation formulations
in-PharmaTechnologist, September 3, 2019
Article / Sep 10, 2019
Inhalation Drug Delivery: The Impact of Particle Size Reduction
Pharmaceutical Technology, September 2, 2019
Contact Us
If you would like to learn more about Hovione, kindly fill in the form below and we will be revert to you soon.